Studies have demonstrated that simultaneous inhibition of FOXM1 and COX-2 promotes inhibition of cell viability, and induces apoptosis in both in vivo and in vitro models of CRC [20]. This evidence concerns the gene PTGS2 and colorectal carcinoma.